Follow
Deni Kukavica
Deni Kukavica
Molecular Cardiology, ICS IRCCS Maugeri Pavia
Verified email at universitadipavia.it
Title
Cited by
Cited by
Year
Natural history and risk stratification in Andersen-Tawil syndrome type 1
A Mazzanti, D Guz, A Trancuccio, E Pagan, D Kukavica, T Chargeishvili, ...
Journal of the American College of Cardiology 75 (15), 1772-1784, 2020
532020
Acute myocarditis associated with desmosomal gene variants
E Ammirati, F Raimondi, N Piriou, L Sardo Infirri, SA Mohiddin, A Mazzanti, ...
Heart Failure 10 (10), 714-727, 2022
502022
An international multicenter evaluation of type 5 long QT syndrome: a low penetrant primary arrhythmic condition
JD Roberts, SY Asaki, A Mazzanti, JM Bos, I Tuleta, AR Muir, L Crotti, ...
Circulation 141 (6), 429-439, 2020
492020
Association of hydroxychloroquine with QTc interval in patients with COVID-19
A Mazzanti, M Briani, D Kukavica, F Bulian, S Marelli, A Trancuccio, ...
Circulation 142 (5), 513-515, 2020
442020
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5
SG Priori, A Mazzanti, DJ Santiago, D Kukavica, A Trancuccio, JC Kovacic
Journal of the American College of Cardiology 77 (20), 2592-2612, 2021
412021
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)
A Mazzanti, A Trancuccio, D Kukavica, E Pagan, M Wang, M Mohsin, ...
EP Europace 24 (4), 614-619, 2022
402022
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
P Jordà, LP Bosman, A Gasperetti, A Mazzanti, JB Gourraud, B Davies, ...
European Heart Journal 43 (32), 3041-3052, 2022
372022
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers
A Mazzanti, D Kukavica, A Trancuccio, M Memmi, R Bloise, P Gambelli, ...
JAMA cardiology 7 (5), 504-512, 2022
312022
Arrhythmic mitral valve prolapse: introducing an era of multimodality imaging-based diagnosis and risk stratification
D Kukavica, M Guglielmo, A Baggiano, G Muscogiuri, L Fusini, M Muratori, ...
Diagnostics 11 (3), 467, 2021
222021
Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy
G Muscogiuri, L Fusini, F Ricci, R Sicuso, M Guglielmo, A Baggiano, ...
International Journal of Cardiology 339, 203-210, 2021
102021
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy
K Addetia, A Mazzanti, R Maragna, L Monti, M Yamat, D Kukavica, ...
European Heart Journal-Cardiovascular Imaging 24 (5), 664-677, 2023
52023
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment—Authors' reply
A Mazzanti, A Trancuccio, D Kukavica, E Pagan, M Wang, M Mohsin, ...
EP Europace 24 (4), 698-699, 2022
42022
Is mexiletine ready for prime time in patients with Type 2 Long QT Syndrome?
A Mazzanti, T Chargeishvili, D Kukavica, M Marino, M Morini, ...
European Heart Journal 41 (Supplement_2), ehaa946. 0750, 2020
32020
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy?
D Kukavica, A Trancuccio, C Arno, AC Latini, A Mazzanti, SG Priori
Minerva Cardiology and Angiology 70 (2), 217-237, 2021
22021
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene
S Zanotti, M Ripolone, L Napoli, D Velardo, S Salani, P Ciscato, S Priori, ...
Cells 12 (10), 1405, 2023
12023
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients
M Wang, DR Peterson, E Pagan, V Bagnardi, A Mazzanti, S McNitt, ...
Frontiers in Cardiovascular Medicine 9, 988951, 2022
12022
Molecular Insights into the Rescue Mechanism of an hERG Activator Against Severe LQT2 Mutations.
A Kumawat, E Tavazzani, G Lentini, A Trancuccio, D Kukavica, M Denegri, ...
bioRxiv, 2024.03. 13.584147, 2024
2024
Unexpected impairment of INa underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome
A Porta-Sánchez, A Mazzanti, C Tarifa, D Kukavica, A Trancuccio, ...
Nature Cardiovascular Research 2 (12), 1291-1309, 2023
2023
Implantable loop recorder monitoring in inherited cardiomyopathies: yield of clinically relevant arrhythmias
A Trancuccio, D Kukavica, G Zvielli, M Marino, P Gambelli, M Memmi, ...
European Heart Journal 44 (Supplement_2), ehad655. 310, 2023
2023
Artificial intelligence-driven echocardiographic classification identifies Brugada Syndrome patients at higher arrhythmic risk
D Kukavica, A Trancuccio, A Esposito, M Marino, R Bloise, C Napolitano, ...
European Heart Journal 44 (Supplement_2), ehad655. 244, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20